REQUEST A DEMO
Total
USD $0.00
Search more companies

Gen Ilac Ve Saglik Urunleri A.S. (Turkiye)

Main Activities: Drugs and Druggists' Sundries Merchant Wholesalers
Full name: Gen Ilac Ve Saglik Urunleri Sanayi Ve Ticaret Anonim Sirketi Profile Updated: April 27, 2023
Buy our report for this company USD 29.95 Most recent financial data: 2022 Available in: English Download a sample report

Gen Ilac Ve Saglik Urunleri A.S. is a company in Turkiye, with a head office in Ankara. The company operates in the Drugs and Druggists' Sundries Merchant Wholesalers industry. It was incorporated on August 12, 1997. 576 (2023) employees currently work for Gen Ilac Ve Saglik Urunleri A.S.. From the latest financial highlights, Gen Ilac Ve Saglik Urunleri A.S. reported a net sales revenue increase of 117.69% in 2022. Its’ total assets recorded a growth of 73.75%. The net profit margin of Gen Ilac Ve Saglik Urunleri A.S. increased by 7.58% in 2022.

Headquarters
D:2-3 No:3 Mustafa Kemal Mahallesi 2119. Sokak Cankaya
Ankara; Central Anatolia; Postal Code: 06530

Contact Details: Purchase the Gen Ilac Ve Saglik Urunleri A.S. report to view the information.

Website: http://www.genilac.com.tr

Basic Information
Total Employees:
Purchase the Gen Ilac Ve Saglik Urunleri A.S. report to view the information.
Outstanding Shares:
Purchase the Gen Ilac Ve Saglik Urunleri A.S. report to view the information.
Registered Capital:
Purchase the Gen Ilac Ve Saglik Urunleri A.S. report to view the information.
Incorporation Date:
August 12, 1997
Key Executives
Purchase this report to view the information.
Chairman
Company Performance
Financial values in the chart are available after Gen Ilac Ve Saglik Urunleri A.S. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency TRY. Absolute financial data is included in the purchased report.
Net sales revenue
117.69%
Total operating revenue
118.74%
Operating profit (EBIT)
170.49%
EBITDA
162.42%
Net Profit (Loss) for the Period
250.68%
Total assets
73.75%
Total equity
118.38%
Operating Profit Margin (ROS)
2.44%
Net Profit Margin
7.58%
Return on Equity (ROE)
14.64%
Debt to Equity Ratio
-0.54%
Quick Ratio
1.1%
Cash Ratio
-0.08%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?